Ole Andreas Halvorsen, 10% Owner at Urovant Sciences Ltd. (UROV), bought 9,995 shares at $8.52 ($85K) on 2019-05-21, disclosed to the SEC on 2019-05-23.
Open-market purchase of $85k UROV by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |
| ZNTL | SELL | 2020-12-03 | $25.3M | — | Filing → |
| ADPT | SELL | 2020-01-30 | $245.4M | — | Filing → |
| ADPT | BUY | 2019-07-02 | $5.0M | — | Filing → |